We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current XNCR market cap is 1.69B. The company's latest EPS is USD -1.8017 and P/E is -13.40.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 59.16M | 44.69M | 12.81M | 16.96M | 10.71M |
| Operating Income | -18.27M | -35.01M | -57.86M | -62.32M | -62.28M |
| Net Income | -24.27M | -19.1M | -68.03M | -65.96M | -45.14M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 156.7M | 122.69M | 275.11M | 164.58M | 168.34M |
| Operating Income | 13.82M | -76.8M | 43.77M | -82.47M | -138.64M |
| Net Income | 26.88M | -69.33M | 82.63M | -55.18M | -126.09M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 778.43M | 952.69M | 884.26M | 826.17M | 983.64M |
| Total Liabilities | 109.42M | 283.56M | 272.07M | 263.63M | 262.74M |
| Total Equity | 669.01M | 669.13M | 612.19M | 562.54M | 720.9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 670.25M | 703.24M | 838.21M | 846.27M | 952.69M |
| Total Liabilities | 77.05M | 130.8M | 104.71M | 118.77M | 283.56M |
| Total Equity | 593.2M | 572.44M | 733.5M | 727.5M | 669.13M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -96.1M | 85.11M | -55.26M | -120.6M | -146.61M |
| Investing | 92.07M | -111.07M | 32.32M | 98.33M | -65.12M |
| Financing | 3.2M | 26.18M | 186k | -757k | 186.98M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 64.37M | -5M | -16.85M | 24.49M | 85.11M |
| Investing | -50.97M | 100.19M | -46.25M | -119.73M | -111.07M |
| Financing | 10.66M | 18.04M | 43.04M | 5.7M | 26.18M |
| Market Cap | 1.69B |
| Price to Earnings Ratio | -13.40 |
| Price to Sales Ratio | 10.04 |
| Price to Cash Ratio | 31.41 |
| Price to Book Ratio | 2.52 |
| Dividend Yield | - |
| Shares Outstanding | 69.98M |
| Average Volume (1 week) | 838.07k |
| Average Volume (1 Month) | 679.51k |
| 52 Week Change | 14.69% |
| 52 Week High | 27.24 |
| 52 Week Low | 15.31 |
| Spread (Intraday) | 14.47 (48.23%) |
| Company Name | Xencor Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.xencor.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
